We investigated factors associated with breast cancer resistance to CDK4/6 inhibitors by downloading the GSE98987, GSE117742, and GSE117743 datasets associated with breast cancer treatment by CDK4/6 inhibitors from the GEO database. This evidence concerns the gene CDK4 and breast carcinoma.